← Back to catalogue

Lucica® Glycated Albumin-L ALB R-1

FDA UDI

Class II (US FDA UDI)

by Asahi Kasei Pharma Corporation

Identity

Trade Name
Lucica® Glycated Albumin-L ALB R-1 FDA UDI
Generic Name
Glycated albumin IVD, reagent FDA UDI
Device Name
ALB R-1 Pretreatment solution 40 mL x 2 FDA UDI
Model / Reference
L232GA FDA UDI
Description
ALB R-1 Pretreatment solution 40 mL x 2 FDA UDI

Identifiers

Catalog Number
L232GA FDA UDI
Primary DI / UDI-DI
04987153301030 FDA UDI
FDA Product Code
LCP FDA UDI
GMDN Term
Glycated albumin IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7470 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Glycated albumin IVD, reagent

Lucica® Glycated Albumin-L ALB R-1 by Asahi Kasei Pharma Corporation — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Glycated albumin IVD, reagent.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Asahi Kasei Pharma Corporation

Sources (1)

  • FDA UDI efefcf64-1e8b-41c1-8433-2838e1048c07 36 fields · synced Jun 1, 2026